Index by author

01 July 2001; volume 18, issue 1

A

  1. Accordini, S.

    1. Cerveri, I. et al "Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults." European Respiratory Journal 18.1 (2001): 85-92. Web. 21 Feb. 2020.

  2. Adnot, S.

    1. Eddahibi, S., and S. Adnot. "Endothelins and pulmonary hypertension, what directions for the near future?." European Respiratory Journal 18.1 (2001): 1-4. Web. 21 Feb. 2020.
    2. Maitre, B. et al "Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury." European Respiratory Journal 18.1 (2001): 100-106. Web. 21 Feb. 2020.

  3. Affrime, M.B.

    1. Affrime, M.B., C. Banfield, and K. Nolop. "Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology." European Respiratory Journal 18.1 (2001): 246. Web. 21 Feb. 2020.

  4. Anderson, R.

    1. Feldman, C. et al "Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro." European Respiratory Journal 18.1 (2001): 122-129. Web. 21 Feb. 2020.

  5. Antonelli, M.

    1. Wysocki, M., and M. Antonelli. "Noninvasive mechanical ventilation in acute hypoxaemic respiratory failure." European Respiratory Journal 18.1 (2001): 209-220. Web. 21 Feb. 2020.

B

  1. Banfield, C.

    1. Affrime, M.B., C. Banfield, and K. Nolop. "Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology." European Respiratory Journal 18.1 (2001): 246. Web. 21 Feb. 2020.

  2. Bara, J.

    1. Roger, P. et al "EGTA treatment of human airways in vitro unmasks M1/MUC5AC mucin in submucosal glands." European Respiratory Journal 18.1 (2001): 176-183. Web. 21 Feb. 2020.

  3. Barkans, J.

    1. Kon, O.M. et al "The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma." European Respiratory Journal 18.1 (2001): 45-52. Web. 21 Feb. 2020.

  4. Barnes, N.C.

    1. Kon, O.M. et al "The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma." European Respiratory Journal 18.1 (2001): 45-52. Web. 21 Feb. 2020.

  5. Bateman, E.D.

    1. Zar, H.J. et al "Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980–1997." European Respiratory Journal 18.1 (2001): 33-37. Web. 21 Feb. 2020.

  6. Bauer, T.T.

    1. et al "European Respiratory Society Guidelines on the use of nebulizers." European Respiratory Journal 18.1 (2001): 228-242. Web. 21 Feb. 2020.

  7. Bergquist, P.

    1. Bergquist, P., and G.K. Crompton. "Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study." European Respiratory Journal 18.1 (2001): 248. Web. 21 Feb. 2020.

  8. Bigatello, L.M.

    1. Chiumello, D. et al "The effects of pressurization rate on breathing pattern, work of breathing, gas exchange and patient comfort in pressure support ventilation." European Respiratory Journal 18.1 (2001): 107-114. Web. 21 Feb. 2020.

  9. Bland, R.M.

    1. Bland, R.M. et al "Total energy expenditure in children with obstructive sleep apnoea syndrome." European Respiratory Journal 18.1 (2001): 164-169. Web. 21 Feb. 2020.

  10. Boe, J.

    1. et al "European Respiratory Society Guidelines on the use of nebulizers." European Respiratory Journal 18.1 (2001): 228-242. Web. 21 Feb. 2020.

  11. Boussat, S.

    1. Maitre, B. et al "Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury." European Respiratory Journal 18.1 (2001): 100-106. Web. 21 Feb. 2020.

  12. Brink, C.

    1. Roger, P. et al "EGTA treatment of human airways in vitro unmasks M1/MUC5AC mucin in submucosal glands." European Respiratory Journal 18.1 (2001): 176-183. Web. 21 Feb. 2020.

  13. Brochard, L.

    1. Maitre, B. et al "Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury." European Respiratory Journal 18.1 (2001): 100-106. Web. 21 Feb. 2020.

  14. Bulgarelli, S.

    1. Bland, R.M. et al "Total energy expenditure in children with obstructive sleep apnoea syndrome." European Respiratory Journal 18.1 (2001): 164-169. Web. 21 Feb. 2020.

  15. Burney, P.

    1. Cerveri, I. et al "Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults." European Respiratory Journal 18.1 (2001): 85-92. Web. 21 Feb. 2020.

C

  1. Cancellieri, A.

    1. Trisolini, R. et al "Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy." European Respiratory Journal 18.1 (2001): 243-245. Web. 21 Feb. 2020.

  2. Carone, M.

    1. et al "European Respiratory Society Guidelines on the use of nebulizers." European Respiratory Journal 18.1 (2001): 228-242. Web. 21 Feb. 2020.

  3. Casaburi, R.

    1. Somfay, A. et al "Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients." European Respiratory Journal 18.1 (2001): 77-84. Web. 21 Feb. 2020.

  4. Casali, L.

    1. Cerveri, I. et al "Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults." European Respiratory Journal 18.1 (2001): 85-92. Web. 21 Feb. 2020.

  5. Cerveri, I.

    1. Cerveri, I. et al "Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults." European Respiratory Journal 18.1 (2001): 85-92. Web. 21 Feb. 2020.

  6. Chiumello, D.

    1. Chiumello, D. et al "The effects of pressurization rate on breathing pattern, work of breathing, gas exchange and patient comfort in pressure support ventilation." European Respiratory Journal 18.1 (2001): 107-114. Web. 21 Feb. 2020.

  7. Chouaïd, C.

    1. Herer, B. et al "Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush." European Respiratory Journal 18.1 (2001): 157-163. Web. 21 Feb. 2020.

  8. Cole, P.J.

    1. Feldman, C. et al "Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro." European Respiratory Journal 18.1 (2001): 122-129. Web. 21 Feb. 2020.

  9. Colier, W.N.J.M.

    1. Van de Ven, M.J.T. et al "Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients." European Respiratory Journal 18.1 (2001): 61-68. Web. 21 Feb. 2020.

  10. Compton, C.H.

    1. Kon, O.M. et al "The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma." European Respiratory Journal 18.1 (2001): 45-52. Web. 21 Feb. 2020.

  11. Corsico, A.

    1. Cerveri, I. et al "Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults." European Respiratory Journal 18.1 (2001): 85-92. Web. 21 Feb. 2020.

  12. Cox, F.M.

    1. Juniper, E.F. et al "Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma." European Respiratory Journal 18.1 (2001): 38-44. Web. 21 Feb. 2020.

  13. Croci, M.

    1. Chiumello, D. et al "The effects of pressurization rate on breathing pattern, work of breathing, gas exchange and patient comfort in pressure support ventilation." European Respiratory Journal 18.1 (2001): 107-114. Web. 21 Feb. 2020.

  14. Crompton, G.K.

    1. Bergquist, P., and G.K. Crompton. "Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study." European Respiratory Journal 18.1 (2001): 248. Web. 21 Feb. 2020.

D

  1. Dahl, R.

    1. Tarp, B. et al "Herpesvirus type 1–8 in BAL fluid from HIV-1-infected patients with suspected pneumonia and from healthy individuals." European Respiratory Journal 18.1 (2001): 146-150. Web. 21 Feb. 2020.

  2. Dasic, G.

    1. Silvestri, M. et al "Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression." European Respiratory Journal 18.1 (2001): 139-145. Web. 21 Feb. 2020.

  3. Dautzenberg, B.

    1. et al "European Respiratory Society Guidelines on the use of nebulizers." European Respiratory Journal 18.1 (2001): 228-242. Web. 21 Feb. 2020.

  4. Delclaux, C.

    1. Maitre, B. et al "Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury." European Respiratory Journal 18.1 (2001): 100-106. Web. 21 Feb. 2020.

  5. de Marco, R.

    1. Cerveri, I. et al "Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults." European Respiratory Journal 18.1 (2001): 85-92. Web. 21 Feb. 2020.

  6. Demontrond, D.

    1. Herer, B. et al "Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush." European Respiratory Journal 18.1 (2001): 157-163. Web. 21 Feb. 2020.

  7. Dennis, J.H.

    1. et al "European Respiratory Society Guidelines on the use of nebulizers." European Respiratory Journal 18.1 (2001): 228-242. Web. 21 Feb. 2020.

  8. Diot, P.

    1. et al "European Respiratory Society Guidelines on the use of nebulizers." European Respiratory Journal 18.1 (2001): 228-242. Web. 21 Feb. 2020.

  9. Dulmet, E.

    1. Roger, P. et al "EGTA treatment of human airways in vitro unmasks M1/MUC5AC mucin in submucosal glands." European Respiratory Journal 18.1 (2001): 176-183. Web. 21 Feb. 2020.

E

  1. Eddahibi, S.

    1. Eddahibi, S., and S. Adnot. "Endothelins and pulmonary hypertension, what directions for the near future?." European Respiratory Journal 18.1 (2001): 1-4. Web. 21 Feb. 2020.

  2. Engström, C.P.

    1. Engström, C.P. et al "Health-related quality of life in COPD: why both disease-specific and generic measures should be used." European Respiratory Journal 18.1 (2001): 69-76. Web. 21 Feb. 2020.

F

  1. Falcone, F.

    1. Trisolini, R. et al "Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy." European Respiratory Journal 18.1 (2001): 243-245. Web. 21 Feb. 2020.

  2. Feldman, C.

    1. Feldman, C. et al "Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro." European Respiratory Journal 18.1 (2001): 122-129. Web. 21 Feb. 2020.

  3. Ferrando, D.

    1. Menéndez, R. et al "Initial risk class and length of hospital stay in community-acquired pneumonia." European Respiratory Journal 18.1 (2001): 151-156. Web. 21 Feb. 2020.

  4. Folgering, H.

    1. Van de Ven, M.J.T. et al "Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients." European Respiratory Journal 18.1 (2001): 61-68. Web. 21 Feb. 2020.

  5. Franquet, T.

    1. Franquet, T.. "Imaging of pneumonia: trends and algorithms." European Respiratory Journal 18.1 (2001): 196-208. Web. 21 Feb. 2020.

  6. Fregonese, L.

    1. Silvestri, M. et al "Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression." European Respiratory Journal 18.1 (2001): 139-145. Web. 21 Feb. 2020.

  7. Frossard, N.

    1. Olgart, C., and N. Frossard. "Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids." European Respiratory Journal 18.1 (2001): 115-121. Web. 21 Feb. 2020.

  8. Fuhrman, C.

    1. Herer, B. et al "Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush." European Respiratory Journal 18.1 (2001): 157-163. Web. 21 Feb. 2020.

  9. Fukuchi, Y.

    1. Takahashi, H. et al "Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery." European Respiratory Journal 18.1 (2001): 5-14. Web. 21 Feb. 2020.

G

  1. Gascard, J-P.

    1. Roger, P. et al "EGTA treatment of human airways in vitro unmasks M1/MUC5AC mucin in submucosal glands." European Respiratory Journal 18.1 (2001): 176-183. Web. 21 Feb. 2020.

  2. Gattinoni, L.

    1. Chiumello, D. et al "The effects of pressurization rate on breathing pattern, work of breathing, gas exchange and patient comfort in pressure support ventilation." European Respiratory Journal 18.1 (2001): 107-114. Web. 21 Feb. 2020.

  3. Gazevic, Z.

    1. Herer, B. et al "Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush." European Respiratory Journal 18.1 (2001): 157-163. Web. 21 Feb. 2020.

  4. Gommers, D.

    1. Vazquez de Anda, G.F. et al "Partial liquid ventilation improves lung function in ventilation-induced lung injury." European Respiratory Journal 18.1 (2001): 93-99. Web. 21 Feb. 2020.

  5. Gouge, M.

    1. Maitre, B. et al "Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury." European Respiratory Journal 18.1 (2001): 100-106. Web. 21 Feb. 2020.

  6. Grimminger, F.

    1. Schütte, H. et al "Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion." European Respiratory Journal 18.1 (2001): 15-22. Web. 21 Feb. 2020.

H

  1. Haitsma, J.J.

    1. Vazquez de Anda, G.F. et al "Partial liquid ventilation improves lung function in ventilation-induced lung injury." European Respiratory Journal 18.1 (2001): 93-99. Web. 21 Feb. 2020.

  2. Herer, B.

    1. Herer, B. et al "Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush." European Respiratory Journal 18.1 (2001): 157-163. Web. 21 Feb. 2020.

  3. Heslop, K.

    1. et al "European Respiratory Society Guidelines on the use of nebulizers." European Respiratory Journal 18.1 (2001): 228-242. Web. 21 Feb. 2020.

  4. Hewitt, C.

    1. Mckean, M.C. et al "A model of viral wheeze in nonasthmatic adults: symptoms and physiology." European Respiratory Journal 18.1 (2001): 23-32. Web. 21 Feb. 2020.

  5. Honoré, E.

    1. Patel, A.J., and E. Honoré. "Molecular physiology of oxygen-sensitive potassium channels." European Respiratory Journal 18.1 (2001): 221-227. Web. 21 Feb. 2020.

  6. Housset, B.

    1. Maitre, B. et al "Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury." European Respiratory Journal 18.1 (2001): 100-106. Web. 21 Feb. 2020.
    2. Herer, B. et al "Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush." European Respiratory Journal 18.1 (2001): 157-163. Web. 21 Feb. 2020.

I

  1. Ienaga, H.

    1. Takahashi, H. et al "Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery." European Respiratory Journal 18.1 (2001): 5-14. Web. 21 Feb. 2020.

J

  1. Jackson, D.

    1. Bland, R.M. et al "Total energy expenditure in children with obstructive sleep apnoea syndrome." European Respiratory Journal 18.1 (2001): 164-169. Web. 21 Feb. 2020.

  2. Jean, D.

    1. Maitre, B. et al "Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury." European Respiratory Journal 18.1 (2001): 100-106. Web. 21 Feb. 2020.

  3. Jensen-Fangel, S.

    1. Tarp, B. et al "Herpesvirus type 1–8 in BAL fluid from HIV-1-infected patients with suspected pneumonia and from healthy individuals." European Respiratory Journal 18.1 (2001): 146-150. Web. 21 Feb. 2020.

  4. Juniper, E.F.

    1. Juniper, E.F. et al "Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma." European Respiratory Journal 18.1 (2001): 38-44. Web. 21 Feb. 2020.

K

  1. Kay, A.B.

    1. Kon, O.M. et al "The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma." European Respiratory Journal 18.1 (2001): 45-52. Web. 21 Feb. 2020.

  2. Kersten, B.T.P.

    1. Van de Ven, M.J.T. et al "Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients." European Respiratory Journal 18.1 (2001): 61-68. Web. 21 Feb. 2020.

  3. Klein, M.

    1. Zar, H.J. et al "Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980–1997." European Respiratory Journal 18.1 (2001): 33-37. Web. 21 Feb. 2020.

  4. Kon, O.M.

    1. Kon, O.M. et al "The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma." European Respiratory Journal 18.1 (2001): 45-52. Web. 21 Feb. 2020.

L

  1. Lachmann, B.

    1. Vazquez de Anda, G.F. et al "Partial liquid ventilation improves lung function in ventilation-induced lung injury." European Respiratory Journal 18.1 (2001): 93-99. Web. 21 Feb. 2020.

  2. Lachmann, R.A.

    1. Vazquez de Anda, G.F. et al "Partial liquid ventilation improves lung function in ventilation-induced lung injury." European Respiratory Journal 18.1 (2001): 93-99. Web. 21 Feb. 2020.

  3. Laghi, F.

    1. Topeli, A., F. Laghi, and M.J. Tobin. "The voluntary drive to breathe is not decreased in hypercapnic patients with severe COPD." European Respiratory Journal 18.1 (2001): 53-60. Web. 21 Feb. 2020.

  4. Lambert, P.C.

    1. Mckean, M.C. et al "A model of viral wheeze in nonasthmatic adults: symptoms and physiology." European Respiratory Journal 18.1 (2001): 23-32. Web. 21 Feb. 2020.

  5. Lannefors, L.

    1. et al "European Respiratory Society Guidelines on the use of nebulizers." European Respiratory Journal 18.1 (2001): 228-242. Web. 21 Feb. 2020.

  6. Larché, M.

    1. Kon, O.M. et al "The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma." European Respiratory Journal 18.1 (2001): 45-52. Web. 21 Feb. 2020.

  7. Larsson, S.

    1. Engström, C.P. et al "Health-related quality of life in COPD: why both disease-specific and generic measures should be used." European Respiratory Journal 18.1 (2001): 69-76. Web. 21 Feb. 2020.

  8. Lazzari Agli, L.

    1. Trisolini, R. et al "Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy." European Respiratory Journal 18.1 (2001): 243-245. Web. 21 Feb. 2020.

  9. Lee, S.M.

    1. Somfay, A. et al "Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients." European Respiratory Journal 18.1 (2001): 77-84. Web. 21 Feb. 2020.

  10. Leech, M.

    1. Mckean, M.C. et al "A model of viral wheeze in nonasthmatic adults: symptoms and physiology." European Respiratory Journal 18.1 (2001): 23-32. Web. 21 Feb. 2020.

  11. Lindahl, M.

    1. Lindbom, J. et al "Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa." European Respiratory Journal 18.1 (2001): 130-138. Web. 21 Feb. 2020.

  12. Lindbom, J.

    1. Lindbom, J. et al "Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa." European Respiratory Journal 18.1 (2001): 130-138. Web. 21 Feb. 2020.

  13. Ljungman, A.G.

    1. Lindbom, J. et al "Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa." European Respiratory Journal 18.1 (2001): 130-138. Web. 21 Feb. 2020.

  14. Löckinger, A.

    1. Schütte, H. et al "Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion." European Respiratory Journal 18.1 (2001): 15-22. Web. 21 Feb. 2020.

  15. Loh, L.C.

    1. Kon, O.M. et al "The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma." European Respiratory Journal 18.1 (2001): 45-52. Web. 21 Feb. 2020.

M

  1. Maitre, B.

    1. Maitre, B. et al "Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury." European Respiratory Journal 18.1 (2001): 100-106. Web. 21 Feb. 2020.

  2. Marc, I.

    1. Sériès, F., and I. Marc. "Importance of sleep stage- and body position-dependence of sleep apnoea in determining benefits to auto-CPAP therapy." European Respiratory Journal 18.1 (2001): 170-175. Web. 21 Feb. 2020.

  3. Martínez, E.

    1. Menéndez, R. et al "Initial risk class and length of hospital stay in community-acquired pneumonia." European Respiratory Journal 18.1 (2001): 151-156. Web. 21 Feb. 2020.

  4. Mckean, M.C.

    1. Mckean, M.C. et al "A model of viral wheeze in nonasthmatic adults: symptoms and physiology." European Respiratory Journal 18.1 (2001): 23-32. Web. 21 Feb. 2020.

  5. Menéndez, R.

    1. Menéndez, R. et al "Initial risk class and length of hospital stay in community-acquired pneumonia." European Respiratory Journal 18.1 (2001): 151-156. Web. 21 Feb. 2020.

  6. Muramatsu, M.

    1. Takahashi, H. et al "Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery." European Respiratory Journal 18.1 (2001): 5-14. Web. 21 Feb. 2020.

  7. Myint, S.

    1. Mckean, M.C. et al "A model of viral wheeze in nonasthmatic adults: symptoms and physiology." European Respiratory Journal 18.1 (2001): 23-32. Web. 21 Feb. 2020.

N

  1. Nolop, K.

    1. Affrime, M.B., C. Banfield, and K. Nolop. "Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology." European Respiratory Journal 18.1 (2001): 246. Web. 21 Feb. 2020.

  2. Norman, G.R.

    1. Juniper, E.F. et al "Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma." European Respiratory Journal 18.1 (2001): 38-44. Web. 21 Feb. 2020.

O

  1. O'Driscoll, B.R.

    1. et al "European Respiratory Society Guidelines on the use of nebulizers." European Respiratory Journal 18.1 (2001): 228-242. Web. 21 Feb. 2020.

  2. Obel, N.

    1. Tarp, B. et al "Herpesvirus type 1–8 in BAL fluid from HIV-1-infected patients with suspected pneumonia and from healthy individuals." European Respiratory Journal 18.1 (2001): 146-150. Web. 21 Feb. 2020.

  3. Oeseburg, B.

    1. Van de Ven, M.J.T. et al "Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients." European Respiratory Journal 18.1 (2001): 61-68. Web. 21 Feb. 2020.

  4. Oka, M.

    1. Takahashi, H. et al "Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery." European Respiratory Journal 18.1 (2001): 5-14. Web. 21 Feb. 2020.

  5. Olgart, C.

    1. Olgart, C., and N. Frossard. "Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids." European Respiratory Journal 18.1 (2001): 115-121. Web. 21 Feb. 2020.

  6. Örtqvist, Å.

    1. Örtqvist, Å.. "Pneumococcal vaccination: current and future issues." European Respiratory Journal 18.1 (2001): 184-195. Web. 21 Feb. 2020.

P

  1. Patel, A.J.

    1. Patel, A.J., and E. Honoré. "Molecular physiology of oxygen-sensitive potassium channels." European Respiratory Journal 18.1 (2001): 221-227. Web. 21 Feb. 2020.

  2. Patelli, M.

    1. Trisolini, R. et al "Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy." European Respiratory Journal 18.1 (2001): 243-245. Web. 21 Feb. 2020.

  3. Paton, J.Y.

    1. Bland, R.M. et al "Total energy expenditure in children with obstructive sleep apnoea syndrome." European Respiratory Journal 18.1 (2001): 164-169. Web. 21 Feb. 2020.

  4. Peacock, A.J.

    1. Saba, T., and A.J. Peacock. "Long-term treatment of pulmonary hypertension with aerosolized iloprost." European Respiratory Journal 18.1 (2001): 247. Web. 21 Feb. 2020.

  5. Pelosi, P.

    1. Chiumello, D. et al "The effects of pressurization rate on breathing pattern, work of breathing, gas exchange and patient comfort in pressure support ventilation." European Respiratory Journal 18.1 (2001): 107-114. Web. 21 Feb. 2020.

  6. Perpiñá, M.

    1. Menéndez, R. et al "Initial risk class and length of hospital stay in community-acquired pneumonia." European Respiratory Journal 18.1 (2001): 151-156. Web. 21 Feb. 2020.

  7. Persson, L.O.

    1. Engström, C.P. et al "Health-related quality of life in COPD: why both disease-specific and generic measures should be used." European Respiratory Journal 18.1 (2001): 69-76. Web. 21 Feb. 2020.

  8. Poletti, V.

    1. Trisolini, R. et al "Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy." European Respiratory Journal 18.1 (2001): 243-245. Web. 21 Feb. 2020.

  9. Porszasz, J.

    1. Somfay, A. et al "Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients." European Respiratory Journal 18.1 (2001): 77-84. Web. 21 Feb. 2020.

R

  1. Reilly, J.J.

    1. Bland, R.M. et al "Total energy expenditure in children with obstructive sleep apnoea syndrome." European Respiratory Journal 18.1 (2001): 164-169. Web. 21 Feb. 2020.

  2. Roberts, J.N.

    1. Juniper, E.F. et al "Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma." European Respiratory Journal 18.1 (2001): 38-44. Web. 21 Feb. 2020.

  3. Roger, P.

    1. Roger, P. et al "EGTA treatment of human airways in vitro unmasks M1/MUC5AC mucin in submucosal glands." European Respiratory Journal 18.1 (2001): 176-183. Web. 21 Feb. 2020.

  4. Rondelli, D.

    1. Trisolini, R. et al "Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy." European Respiratory Journal 18.1 (2001): 243-245. Web. 21 Feb. 2020.

  5. Rossi, G.A.

    1. Silvestri, M. et al "Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression." European Respiratory Journal 18.1 (2001): 139-145. Web. 21 Feb. 2020.

S

  1. Saba, T.

    1. Saba, T., and A.J. Peacock. "Long-term treatment of pulmonary hypertension with aerosolized iloprost." European Respiratory Journal 18.1 (2001): 247. Web. 21 Feb. 2020.

  2. Sabatini, F.

    1. Silvestri, M. et al "Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression." European Respiratory Journal 18.1 (2001): 139-145. Web. 21 Feb. 2020.

  3. Schütte, H.

    1. Schütte, H. et al "Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion." European Respiratory Journal 18.1 (2001): 15-22. Web. 21 Feb. 2020.

  4. Seeger, W.

    1. Schütte, H. et al "Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion." European Respiratory Journal 18.1 (2001): 15-22. Web. 21 Feb. 2020.

  5. Sériès, F.

    1. Sériès, F., and I. Marc. "Importance of sleep stage- and body position-dependence of sleep apnoea in determining benefits to auto-CPAP therapy." European Respiratory Journal 18.1 (2001): 170-175. Web. 21 Feb. 2020.

  6. Sihra, B.S.

    1. Kon, O.M. et al "The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma." European Respiratory Journal 18.1 (2001): 45-52. Web. 21 Feb. 2020.

  7. Silverman, M.

    1. Mckean, M.C. et al "A model of viral wheeze in nonasthmatic adults: symptoms and physiology." European Respiratory Journal 18.1 (2001): 23-32. Web. 21 Feb. 2020.

  8. Silvestri, M.

    1. Silvestri, M. et al "Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression." European Respiratory Journal 18.1 (2001): 139-145. Web. 21 Feb. 2020.

  9. Soma, S.

    1. Takahashi, H. et al "Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery." European Respiratory Journal 18.1 (2001): 5-14. Web. 21 Feb. 2020.

  10. Somfay, A.

    1. Somfay, A. et al "Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients." European Respiratory Journal 18.1 (2001): 77-84. Web. 21 Feb. 2020.

  11. Steel, H.C.

    1. Feldman, C. et al "Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro." European Respiratory Journal 18.1 (2001): 122-129. Web. 21 Feb. 2020.

  12. Stickells, D.

    1. Zar, H.J. et al "Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980–1997." European Respiratory Journal 18.1 (2001): 33-37. Web. 21 Feb. 2020.

  13. Sullivan, M.

    1. Engström, C.P. et al "Health-related quality of life in COPD: why both disease-specific and generic measures should be used." European Respiratory Journal 18.1 (2001): 69-76. Web. 21 Feb. 2020.

T

  1. Tagesson, C.

    1. Lindbom, J. et al "Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa." European Respiratory Journal 18.1 (2001): 130-138. Web. 21 Feb. 2020.

  2. Takahashi, H.

    1. Takahashi, H. et al "Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery." European Respiratory Journal 18.1 (2001): 5-14. Web. 21 Feb. 2020.

  3. Tarp, B.

    1. Tarp, B. et al "Herpesvirus type 1–8 in BAL fluid from HIV-1-infected patients with suspected pneumonia and from healthy individuals." European Respiratory Journal 18.1 (2001): 146-150. Web. 21 Feb. 2020.

  4. Tassinari, D.

    1. Trisolini, R. et al "Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy." European Respiratory Journal 18.1 (2001): 243-245. Web. 21 Feb. 2020.

  5. Theron, A.J.

    1. Feldman, C. et al "Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro." European Respiratory Journal 18.1 (2001): 122-129. Web. 21 Feb. 2020.

  6. Tobin, M.J.

    1. Topeli, A., F. Laghi, and M.J. Tobin. "The voluntary drive to breathe is not decreased in hypercapnic patients with severe COPD." European Respiratory Journal 18.1 (2001): 53-60. Web. 21 Feb. 2020.

  7. Toerien, A.

    1. Zar, H.J. et al "Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980–1997." European Respiratory Journal 18.1 (2001): 33-37. Web. 21 Feb. 2020.

  8. Topeli, A.

    1. Topeli, A., F. Laghi, and M.J. Tobin. "The voluntary drive to breathe is not decreased in hypercapnic patients with severe COPD." European Respiratory Journal 18.1 (2001): 53-60. Web. 21 Feb. 2020.

  9. Trisolini, R.

    1. Trisolini, R. et al "Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy." European Respiratory Journal 18.1 (2001): 243-245. Web. 21 Feb. 2020.

V

  1. Vallés, J.M.

    1. Menéndez, R. et al "Initial risk class and length of hospital stay in community-acquired pneumonia." European Respiratory Journal 18.1 (2001): 151-156. Web. 21 Feb. 2020.

  2. Van der Sluijs, M.C.

    1. Van de Ven, M.J.T. et al "Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients." European Respiratory Journal 18.1 (2001): 61-68. Web. 21 Feb. 2020.

  3. Van de Ven, M.J.T.

    1. Van de Ven, M.J.T. et al "Ventilatory and cerebrovascular responses in normocapnic and hypercapnic COPD patients." European Respiratory Journal 18.1 (2001): 61-68. Web. 21 Feb. 2020.

  4. van Rensburg, C.E.J.

    1. Feldman, C. et al "Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro." European Respiratory Journal 18.1 (2001): 122-129. Web. 21 Feb. 2020.

  5. Vazquez de Anda, G.F.

    1. Vazquez de Anda, G.F. et al "Partial liquid ventilation improves lung function in ventilation-induced lung injury." European Respiratory Journal 18.1 (2001): 93-99. Web. 21 Feb. 2020.

  6. Ventham, J.C.

    1. Bland, R.M. et al "Total energy expenditure in children with obstructive sleep apnoea syndrome." European Respiratory Journal 18.1 (2001): 164-169. Web. 21 Feb. 2020.

  7. Verbrugge, S.J.C.

    1. Vazquez de Anda, G.F. et al "Partial liquid ventilation improves lung function in ventilation-induced lung injury." European Respiratory Journal 18.1 (2001): 93-99. Web. 21 Feb. 2020.

  8. Verlato, G.

    1. Cerveri, I. et al "Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults." European Respiratory Journal 18.1 (2001): 85-92. Web. 21 Feb. 2020.

W

  1. Wilson, D.

    1. Zar, H.J. et al "Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980–1997." European Respiratory Journal 18.1 (2001): 33-37. Web. 21 Feb. 2020.

  2. Wilson, R.

    1. Feldman, C. et al "Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro." European Respiratory Journal 18.1 (2001): 122-129. Web. 21 Feb. 2020.

  3. Wysocki, M.

    1. Wysocki, M., and M. Antonelli. "Noninvasive mechanical ventilation in acute hypoxaemic respiratory failure." European Respiratory Journal 18.1 (2001): 209-220. Web. 21 Feb. 2020.

Z

  1. Zar, H.J.

    1. Zar, H.J. et al "Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980–1997." European Respiratory Journal 18.1 (2001): 33-37. Web. 21 Feb. 2020.

  2. Zoia, M.C.

    1. Cerveri, I. et al "Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults." European Respiratory Journal 18.1 (2001): 85-92. Web. 21 Feb. 2020.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts